A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9–12 month old healthy infants

por Thuluva, Subhash, Gunneri, SubbaReddy, Turaga, Kishore, Mogulla, Rammohan Reddy, Yerroju, Vijay, Peta, Kalyankumar, Suneetha, Pothakamuri Venkata, Matur, Ramesh V.
Publicado 2023